This video provides a comprehensive overview of pediatric asthma, focusing on how to approach a wheezing child. It differentiates between stridor and wheezing, explaining their causes and characteristics…
This video features a presentation at the Best of Lung 2023 conference. Jaime Schneider, MD discusses the latest advancements in targeted therapies for lung cancer. They highlight the…
NEW YORK (Reuters Health) – The presence of deep venous thrombosis (DVT) in patients with pulmonary embolism is associated with an increased risk of death, according to a…
NEW YORK (Reuters Health) – A single negative whole-leg compression ultrasound (CUS) can effectively rule out deep vein thrombosis (DVT) in many patients, according to a meta-analysis in…
NEW YORK (Reuters Health) – Starting heparin in the emergency department (ED) rather than after admission may improve the survival of patients with acute pulmonary embolism (PE), according…
NEW YORK (Reuters Health) – Only two visits to the pulmonary function lab — one for pre- and post-bronchodilatory spirometry and one for a methacholine challenge test —…
NEW YORK (Reuters Health) – Clinical prediction rules for judging the likelihood of a pulmonary embolism (PE) could be improved, new research shows. Now the rules leave out…
NEW YORK (Reuters Health) – Active tuberculosis is more readily found with commercially available interferon-gamma release assays than with tuberculin skin tests, according to a meta-analysis. Furthermore, when…
NEW YORK (Reuters Health) – When allergic asthma in children can’t be controlled with medium- to high-dose corticosteroids, add-on omalizumab is effective and well tolerated, new research shows.…
NEW YORK (Reuters Health) – More than a third of patients undergoing routine outpatient endoscopic procedures are at high risk for obstructive sleep apnea (OSA), according to findings…
NEW YORK (Reuters Health) – For diagnosing pulmonary embolism, single-photon emission CT (SPECT) lung scintigraphy is a viable alternative to CT pulmonary angiography (CTPA), and it offers advantages…
NEW YORK (Reuters Health) – An investigational drug called motavizumab may offer better protection against respiratory syncytial virus (RSV) than palivizumab in high risk children, according to a…
